European Archives - Page 99 of 1112 - European Medical Journal

Molecular Dynamics Behind Different Tumour Rejection Kinetics in CAR-T Cell Therapy

A recent study has uncovered key insights into the differing tumour rejection behaviours of chimeric antigen receptor T cells (CAR-T) targeting CD19…

Anna Sureda

Hema Now: Episode 9: A Conversation with the EBMT President

Anna Sureda, Head of the Clinical Hematology Department, Institut Català d’Oncologia – Hospital Duran i Reynals, Barcelona, Spain; President of the European Society for Blood and Marrow Transplantation (EBMT)

New Guidelines Provide Key Recommendations for Managing Hepatitis B Reactivation Risk

A newly updated clinical practice guideline offers healthcare practitioners vital evidence-based recommendations for managing hepatitis B reactivation (HBVr) in individuals at risk.

Medicine in the Metaverse: An Interview with Shafi Ahmed

Shafi Ahmed, a world-renowned surgeon, futurist, innovator, professor, and Nobel Peace Prize nominee, shares exclusive insights…

Gut Microbiota Modulation: A Solution for Allergic Rhinitis

This study highlights the potential of probiotics as an adjunct treatment for allergic rhinitis, offering symptom relief and improving quality of life.

Virtual Reality Subway Simulation Reveals the Impact of Sound on Balance Disorders

VR study reveals sound disrupts balance for those with inner ear disorders, aiding new clinical therapies.

New Model for Predicting Atherosclerotic Cardiovascular Disease in Individuals with Obesity

Discover AROSE, a new equation to better predict ASCVD risk in individuals with obesity, outperforming current models.

Study Reveals Infection Trends in Patients With Ankylosing Spondylitis on Biologics

A study using the KOBIO registry reveals a 39 per 1,000 person-year infection rate in ankylosing spondylitis (AS) patients receiving biologics. Respiratory tract infections and herpes zoster were the most common, with age, diabetes, and kidney disease among key risk factors.

Isosorbide Mononitrate Eases Labour Induction, Study Finds

A groundbreaking clinical trial has demonstrated that isosorbide mononitrate (ISMN), a nitric oxide donor, effectively shortens labour induction time by promoting cervical ripening.

Study Sheds Light on the Role of HER2 in Male Breast Cancer

A recent comprehensive study has offered new insights into the role of human epidermal growth factor 2 (HER2) in male breast cancer…